ProKidney Corp. reported Tuesday a larger first-quarter loss at $16.7 million as the Winston-Salem biopharmaceutical manufacturer enters a pivotal clinical trial performance period.

But rather than sort through these people, to do the hard, slow work of separating the vicious from the well-meaning, the Trump administration is whipping up an emergency to justify acting in bad ...